TYK2 and Systemic Sclerosis Susceptibility: a New Associated Locus in the IL-12 Pathway

Elena López‐Isac, Torsten Witte, C.P. Simeón, Lara Bossini‐Castillo, Shervin Assassi(University of Houston), Alexandre E. Voskuyl(Amsterdam Neuroscience), Gianluca Moroncini(Marche Polytechnic University), JK de Vries-Bouwstra, Chiara Bellocchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), TRDJ Radstake, Ariane L. Herrick(University of Salford), Claudio Lunardi(University of Verona), Norberto Ortego‐Centeno, G. Riemekasten(Charité - Universitätsmedizin Berlin), Patrícia Carreira, Mayes, Jhw Distler, Armando Gabrielli(Marche Polytechnic University), CP Denton(The Royal Free Hospital), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Carla Fonseca, Lorenzo Beretta
Kölner Universitäts PublikationsServer (Universität zu Köln)
January 1, 2015
Cited by 0

Related Papers

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432